Stocks and Investing
Stocks and Investing
Fri, May 19, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ed Arce Reiterated (TERN) at Hold and Held Target at $11 on, May 19th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Terns Pharmaceuticals, Inc." (TERN) at Hold and Held Target at $11 on, May 19th, 2023.
Ed has made no other calls on TERN in the last 4 months.
There are 4 other peers that have a rating on TERN. Out of the 4 peers that are also analyzing TERN, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eric Joseph of "JP Morgan" Maintained at Hold with Increased Target to $10 on, Tuesday, May 16th, 2023
These are the ratings of the 3 analyists that currently disagree with Ed
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $17 on, Tuesday, May 16th, 2023
- Etzer Darout of "BMO Capital" Initiated at Buy and Held Target at $18 on, Monday, May 8th, 2023
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $19 on, Tuesday, February 7th, 2023
Contributing Sources